1. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence;Newcomer;J Clin Psychiatry,2007
2. Cardiovascular morbidity and mortality associated with the metabolic syndrome;Isomaa;Diabetes Care,2001
3. Congruencies in increased mortality rates, years of potential life lost and causes of death among public mental health clients in eight states;Coltron;Prev Chronic Dis,2006
4. Prévalence des pathologies psychiatriques en médecine générale;Thomas;Rev Med Brux,2004
5. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom;Ohayon;J Clin Psychiatry,2002